Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo study
Open Access
- 1 January 2009
- journal article
- Published by Springer Nature in Thrombosis Journal
- Vol. 7 (1) , 14
Abstract
Low molecular weight heparin (LMWH) is in vast usage for treatment of thromboembolic diseases such as deep venous thrombosis and acute coronary syndromes. There are certain clinical situations where a quick point of care testing of the effect of LMWH would be useful. At this point there are no point of care devices available in the market for monitoring the effect of LMWH. Thrombelastography (TEG) evaluates the viscoelastic properties of blood during coagulation. The clinical application of TEG in monitoring LMWH treatment is not yet well defined. The purpose of this in vivo study was to systematically evaluate the most suitable TEG parameters for evaluation of the antithrombotic effect of LMWH. We furthermore evaluated for the first time the usefulness of the composite TEG parameter the Thrombodynamic Ratio (TDR) in monitoring LMWH treatment.Keywords
This publication has 21 references indexed in Scilit:
- Thrombelastography monitoring of resistance to enoxaparin anticoagulation in thrombophilic pregnancy patientsThrombosis Research, 2007
- High-dose tinzaparin in pregnancy and the need for urgent deliveryBritish Journal of Anaesthesia, 2002
- Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicineAmerican Heart Journal, 2000
- Thromboelastography as a Perioperative Measure of Anticoagulation Resulting from Low Molecular Weight Heparin: A Comparison with Anti-Xa ConcentrationsAnesthesia & Analgesia, 2000
- Effects of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Heparinoid on Thromboelastographic Assay of Blood CoagulationAmerican Journal of Clinical Pathology, 2000
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery DiseaseCirculation, 1997
- THROMBELASTOGRAPHY AFTER ASPIRIN INGESTION IN PREGNANT AND NON-PREGNANT SUBJECTSBritish Journal of Anaesthesia, 1992
- Usefulness of Thrombelastography for Dosage Monitoring of Low Molecular Weight Heparin and Unfractionated Heparin During HemodialysisArtificial Organs, 1990